Novartis in Society ESG Report

Mother visits sickle cell screening program for newborns at Kumasi General Hospital, Ghana.
  • Our Impact

Novartis in Society ESG Report

We aim to take real, measurable and reportable action on key environmental, social and governance topics.

Download the Novartis in Society ESG Report

Letter from our CEO

“We aspire to be a leader on environmental, social and governance topics and to build trust with society. In the long run, that’s what will enable us to continue reimagining medicine.”

Vas Narasimhan, CEO Novartis

Read the CEO letter 

For more information on our key corporate responsibility issues click here.

Our strategic priorities

Ethical Standards

We are committed to meeting the highest ethical standards in what we do, and we are taking steps to earn and maintain the trust of patients, associates, partners, shareholders and society.

Read the chapter

Access to Healthcare

As a global medicines company, we embrace our responsibility to society to help ensure our innovative treatments benefit more people who need them, no matter where they live.

Read the chapter

Global Health

Novartis has a long heritage in tackling infectious and neglected tropical diseases. We continue to play a significant role in global movements to end leprosy and malaria, while initiating new efforts to tackle sickle cell disease and Chagas disease.

Read the chapter

Responsible Citizenship

Strong leadership is needed now more than ever to move beyond business as usual and catalyze a global response to complex societal challenges like climate change.

Read the chapter

To access reports from prior years, visit the CR Report Archive.